- Home
- PYPD vs LITB Comparison
PYPD vs LITB Comparison
Compare PYPD & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- LITB
- Stock Information
- Founded
- PYPD 2008
- LITB 2007
- Country
- PYPD Israel
- LITB Singapore
- Employees
- PYPD N/A
- LITB N/A
- Industry
- PYPD Medical/Dental Instruments
- LITB Catalog/Specialty Distribution
- Sector
- PYPD Health Care
- LITB Consumer Discretionary
- Exchange
- PYPD Nasdaq
- LITB Nasdaq
- Market Cap
- PYPD 34.8M
- LITB 38.0M
- IPO Year
- PYPD 2020
- LITB N/A
- Fundamental
- Price
- PYPD $3.49
- LITB $2.01
- Analyst Decision
- PYPD Strong Buy
- LITB
- Analyst Count
- PYPD 5
- LITB 0
- Target Price
- PYPD $12.00
- LITB N/A
- AVG Volume (30 Days)
- PYPD 52.0K
- LITB 66.1K
- Earning Date
- PYPD 11-12-2025
- LITB 09-09-2025
- Dividend Yield
- PYPD N/A
- LITB N/A
- EPS Growth
- PYPD N/A
- LITB N/A
- EPS
- PYPD N/A
- LITB 0.12
- Revenue
- PYPD N/A
- LITB $220,656,000.00
- Revenue This Year
- PYPD N/A
- LITB N/A
- Revenue Next Year
- PYPD N/A
- LITB N/A
- P/E Ratio
- PYPD N/A
- LITB $17.83
- Revenue Growth
- PYPD N/A
- LITB N/A
- 52 Week Low
- PYPD $2.30
- LITB $0.91
- 52 Week High
- PYPD $3.93
- LITB $3.50
- Technical
- Relative Strength Index (RSI)
- PYPD 54.23
- LITB 67.40
- Support Level
- PYPD $3.35
- LITB $2.02
- Resistance Level
- PYPD $3.54
- LITB $2.32
- Average True Range (ATR)
- PYPD 0.12
- LITB 0.24
- MACD
- PYPD 0.00
- LITB 0.05
- Stochastic Oscillator
- PYPD 75.49
- LITB 72.61
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.